MB Lilly
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Immunology top 10%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
Papers in
-
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 3
- Chronic Myeloid Leukemia Treatments 1
- Oncology 4
- Cytokine Signaling Pathways and Interactions 4
- Chemokine receptors and signaling 1
- Neutropenia and Cancer Infections 1
- Co-authors
- TA Rado (2 shared papers)Jack W. Singer (4 shared papers)Mark R. Alderson (1 shared paper)John J. Nemunaitis (1 shared paper)Andrews Df (1 shared paper)Andrew S. Kraft (2 shared papers)George R. Pettit (1 shared paper)Jian Li (1 shared paper)
- Journals
- Blood (4 papers)Leukemia Research (1 paper)PubMed (4 papers)
- Partner nations
- United StatesFrance
In The Last Decade
MB Lilly
9 papers receiving 471 citations
Peers
Comparison fields: 5 of 48
- Hematology 127
- Immunology 152
- Genetics 36
- Oncology 89
- Immunology and Allergy 10
Countries citing papers authored by MB Lilly
This map shows the geographic impact of MB Lilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MB Lilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MB Lilly more than expected).
Fields of papers citing papers by MB Lilly
This network shows the impact of papers produced by MB Lilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MB Lilly. The network helps show where MB Lilly may publish in the future.
Co-authors
The 12 scholars most cited alongside MB Lilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 203 | |
| 2 | 1993 | 86 | |
| 3 | 1989 | 60 | |
| 4 | 1989 | 51 | |
| 5 | Production of granulocyte colony-stimulating factor by a human melanoma cell line. | 1987 | 43 |
| 6 | Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin. | 1990 | 23 |
| 7 | Nontransformed colony-derived stromal cell lines from normal human marrows. I. Growth requirement and myelopoiesis supportive ability. | 1995 | 22 |
| 8 | Sodium vanadate, a tyrosine phosphatase inhibitor, affects expression of hematopoietic growth factors and extracellular matrix RNAs in SV40-transformed human marrow stromal cells. | 1992 | 5 |
| 9 | 1988 | 2 |
About MB Lilly
MB Lilly is a scholar working on Hematology, Oncology, Genetics, Immunology and Molecular Biology, having authored 9 papers that have together received 495 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (4 papers), Cytokine Signaling Pathways and Interactions (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Chronic Myeloid Leukemia Treatments (1 paper), Protein Tyrosine Phosphatases (1 paper), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper), Chemokine receptors and signaling (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Hematology (127 citations), Immunology (152 citations), Genetics (36 citations), Oncology (89 citations) and Immunology and Allergy (10 citations). MB Lilly has collaborated with scholars based in United States and France. Frequent co-authors include TA Rado, Jack W. Singer, Mark R. Alderson, John J. Nemunaitis, Andrews Df, Andrew S. Kraft, George R. Pettit, Jian Li, Luc Sensebé and P Hervé. Their work appears in journals such as Blood, Leukemia Research and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.